Target intelligence / Profile preview

RNA, U6 small nuclear 809, pseudogene (RNU6-809P)

Target
RNU6-809P
Molecular classification
Other (non-coding RNA, small nuclear RNA pseudogene)
01

Overview

RNU6-809P is a pseudogene derived from the U6 small nuclear RNA gene. The functional U6 snRNA is central to the spliceosome, cooperating with other snRNAs and proteins to catalyze removal of introns from pre-mRNA in the nucleus—a critical step in gene expression in eukaryotes[1][3]. RNU6-809P, however, is a non-coding pseudogene variant and is not known to contribute directly to splicing or any other biological activity. Some pseudogenes have been implicated in gene regulation as miRNA decoys or competing endogenous RNAs (ceRNAs), but there is no specific evidence that RNU6-809P serves any such function[4]. In general, pseudogenes like RNU6-809P lack therapeutic relevance, do not act as receptors, enzymes, or other drug targets, and are not used as biomarkers in clinical practice[1][3][4].

Other names
RNU6-809PU6 small nuclear 809, pseudogeneRNA, U6-809P
02

Mechanism of action

None (No known drugs target or modulate pseudogene function)

03

Biological functions

Typically none for the pseudogene itself; functional U6 snRNA mediates pre-mRNA splicing in the spliceosome
04

Disease associations

None established for RNU6-809P itself; emerging evidence suggests some pseudogenes may act as competing endogenous RNAs (ceRNAs) and potentially regulate parental genes, but no specific disease role or therapeutic targeting is described for this entry
05

Safety considerations

None (There are no safety concerns or therapeutic challenges associated directly with this pseudogene)
06

Interacting drugs

None (No drugs interact with pseudogenes like RNU6-809P; there is no evidence for direct pharmacological modulation)
07

Biomarkers

None (RNU6-809P is not used as a clinical biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 809, pseudogene (RNU6-809P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 809, pseudogene (RNU6-809P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call